Zobrazeno 1 - 10
of 31
pro vyhledávání: '"J R, Hartmann"'
Autor:
J R Hartmann, Paul A. Gurbel, M J Kern, M J Frey, Barry S. George, R J Freedman, Erik Magnus Ohman, J D Talley, Christopher J. White, C Lundergan
Publikováno v:
Circulation. 90:792-799
BACKGROUND Aortic counterpulsation has been observed to reduce the rate of reocclusion of the infarct-related artery after patency has been restored during acute myocardial infarction in observational studies. To evaluate the benefit-to-risk ratio of
Autor:
J R, Hartmann
Publikováno v:
The Journal of invasive cardiology. 7
The problem of aorto-coronary vein graft occlusion remains a major clinical challenge. The approach described above offers one method of preserving the life of some occluded vein grafts. This study was done before the release of the coronary stent. T
Publikováno v:
Journal of the American College of Cardiology. 24(5)
Three dosage regimens of a new recombinant glycosylated prourokinase (A-74187) were evaluated by measuring coronary artery patency at 90 min in patients with acute myocardial infarction.Prourokinase is a thrombolytic drug with unique pharmacologic pr
Publikováno v:
Catheterization and cardiovascular diagnosis.
Balloon angioplasty of aorto-ostial right coronary artery (RCA) and aorto-ostial saphenous vein graft (SVG) stenoses has been reported to be associated with a suboptimal acute success rate, a higher incidence of restenosis and an increased risk of em
Autor:
Buckner Cd, John Hersman, Thomas Ed, Rainer Storb, J R Hartmann, R L Chard, Reginald A. Clift, F L Jonson
Publikováno v:
Archives of Disease in Childhood. 51:403-410
Seventy-six patients, aged 2 to 17 years, were treated with bone marrow transplantation for severe aplastic anaemia or acute leukaemia refractory to conventional therapy. 16 of the 22 patients (73%) who received marrow transplantations for aplastic a
Publikováno v:
ChemInform. 19
Publikováno v:
Cancer. 41(1)
The last 20 years have witnessed remarkable improvements in the prognosis of children with many forms of malignant disease. The reasons for these improvements relate not only to the development of better drugs and more effective radiotherapy, but als
Publikováno v:
Cancer. 34(6)
Publikováno v:
Cancer treatment reports. 62(7)
Publikováno v:
The Journal of pediatrics. 84(4)